drugset / Trial / NCT03306914

Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

NCT03306914

Completed 120 enrolled Cairo University
RandomizedParallel-groupSingle-blindSupportive care

Summary

In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.

Timeline

Start
2017-10-15
Primary completion
2019-02-01
Completion
2019-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic 5 %
Subject hydroxyethyl starch Other / unclassified 6 %

Indications

No indication recorded.